Cargando…
Advances against Aspergillosis and Mucormycosis
Autor principal: | Stevens, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770581/ https://www.ncbi.nlm.nih.gov/pubmed/33322425 http://dx.doi.org/10.3390/jof6040358 |
Ejemplares similares
-
Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
por: Donnelley, Monica A, et al.
Publicado: (2016) -
Oral Mucormycosis and Aspergillosis in the Patient with Acute Leukemia
por: Vučićević Boras, Vanja, et al.
Publicado: (2019) -
Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
por: Banck, Jan Christoph, et al.
Publicado: (2021) -
COVID-19 associated with concomitant mucormycosis and aspergillosis
por: Lai, Chih-Cheng, et al.
Publicado: (2022) -
Dexamethasone: Pulmonary aspergillosis and mucormycosis: case report
Publicado: (2021)